Policy → market

Market alerts

Not financial advice

Commercial cliffs from presidential documents — role pressure, mechanisms, and a curated issuer watchlist. Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

How this works
  1. Cliff vs glide — dates that change market access differ from multi-year programs.
  2. Role pressure — protective / adverse / mixed for supply-chain roles (not a stock tip).
  3. Named issuers — curated watchlist only.
  4. Price window — optional EOD chart around issue and cliff dates; coincidence, not causation.
Clear
  1. in 33dIssued Aug 14, 2026

    Delivering Gold Standard Childhood Vaccine Recommendations for Americans

    HHS Task Force on Safer Childhood Vaccines presents plans to President through Assistant to the President for Domestic Policy

    EO 144208/10ProcurementLicensingPharmaTechIndustrialUSEUOTHER
    MMM3MGOOGLAlphabetAAPLAppleCATCaterpillarLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywell
  2. in 49dIssued Nov 28, 2025

    Launching the Genesis Mission

    First annual report to President on Platform status, outcomes, and partnerships

    EO 143638/10Quiet signalProcurementSubsidy / incentiveLicensingSemiTechDefenseMineralsOil/gasPharmaUSCNEUJP
    ALBAlbemarleGOOGLAlphabetAAPLAppleAMATApplied MaterialsASMLASMLBABoeingAVGOBroadcomLNGCheniere Energy
  3. in 53dIssued Oct 2, 2026

    Eliminating Disease-Carrying Pests and Restoring Enjoyment of the Great Outdoors

    EPA regulatory framework for advanced pest control technologies due; campaign development begins; alpha-gal labeling exploration due

    EO 144336/10Subsidy / incentiveProcurementLicensingPharmaAgTechChemIndustrialUS
    MMM3MALBAlbemarleGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillar
  4. in 83dIssued Oct 2, 2026

    Eliminating Disease-Carrying Pests and Restoring Enjoyment of the Great Outdoors

    HHS prize competitions for diagnostics/therapeutics; alpha-gal immunotherapy review; Agriculture prize competitions for non-chemical methods

    EO 144336/10Subsidy / incentiveProcurementLicensingPharmaAgTechChemIndustrialUS
    MMM3MALBAlbemarleGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillar
  5. in 106dIssued Jan 14, 2026

    Continuation of the National Emergencies With Respect to the Southern Border of the United States and Cartels and Other Transnational Organizations

    Proclamation 10886 and EO 14157 one-year continuation expires unless renewed

    Notice6/10Quiet signalTariffBan / prohibitionAutosAgChemOil/gasPharmaLogisticsUSCAMXCN
    MMM3MALBAlbemarleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillarLNGCheniere EnergyCVXChevron
  6. in 118dIssued Jan 14, 2026

    Continuation of the National Emergencies With Respect to the Southern Border of the United States and Cartels and Other Transnational Organizations

    EO 14193, EO 14194, and EO 14195 one-year continuation expires unless renewed

    Notice6/10Quiet signalTariffBan / prohibitionAutosAgChemOil/gasPharmaLogisticsUSCAMXCN
    MMM3MALBAlbemarleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillarLNGCheniere EnergyCVXChevron
  7. in 178dIssued Mar 27, 2026

    Continuation of the National Emergency With Respect to Trade Practices That Contribute to Large and Persistent Annual United States Goods Trade Deficits

    Continued national emergency expires unless further extended

    Notice6/10Quiet signalTariffBan / prohibitionLicensingMetalsAutosAgTechPharmaMineralsUSCNEUMX
    ALBAlbemarleAAAlcoaGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBGBungeCATCaterpillarCENXCentury Aluminum
  8. in 837dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    Zero tariff rate expires for companies with MFN pricing agreements

    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  9. in 1274dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    20% onshoring rate increases to 100%

    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  10. Issued Jul 16, 2026

    Regulatory Relief for Certain Stationary Sources To Promote American Chemical Manufacturing Security

    This proclamation grants a 2-year exemption from certain EPA emissions-control requirements (the HON Rule) for specific

    Proc 110417/10Quiet signalLicensingChemSemiDefenseAgPharmaOil/gasUS
    MMM3MALBAlbemarleAMATApplied MaterialsADMArcher Daniels MidlandASMLASMLBASFYBASFBABoeingAVGOBroadcom
  11. Issued Apr 22, 2026

    Accelerating Medical Treatments for Serious Mental Illness

    This executive order directs federal agencies to accelerate research, regulatory review, and patient access to psychedel

    EO 144017/10Quiet signalSubsidy / incentiveLicensingProcurementPharmaTechUS
    GOOGLAlphabetAAPLAppleLLYEli LillyQQQInvesco QQQ TrustJNJJohnson & JohnsonMRKMerckMETAMeta PlatformsMSFTMicrosoft
  12. Issued Jul 23, 2025

    Regulatory Relief for Certain Stationary Sources To Promote American Chemical Manufacturing Security

    This proclamation grants a 2-year exemption from certain EPA emissions-control requirements (the HON Rule) for specific

    Proc 109577/10Quiet signalLicensingChemSemiDefenseAgPharmaOil/gasUS
    MMM3MALBAlbemarleAMATApplied MaterialsADMArcher Daniels MidlandASMLASMLBASFYBASFBABoeingAVGOBroadcom
  13. Issued Mar 20, 2025

    Additional Rescissions of Harmful Executive Orders and Actions

    This executive order revokes 18 additional Biden-era executive actions, building on an earlier January 2025 order that r

    EO 142367/10Quiet signalSubsidy / incentiveProcurementLicensingSolarMetalsOil/gasChemDefensePharmaUSCNEUKR
    MMM3MALBAlbemarleAAAlcoaBASFYBASFBABoeingCSIQCanadian SolarCENXCentury AluminumLNGCheniere Energy
  14. Issued Feb 26, 2025

    Defending American Companies and Innovators From Overseas Extortion and Unfair Fines and Penalties

    This memorandum directs multiple agencies to investigate and counter foreign tax and regulatory practices—particularly d

    Memo7/10Quiet signalTariffLicensingProcurementTechMetalsAutosAeroAgPharmaUSUKCAEU
    EADSYAirbusAAAlcoaGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBABoeingBGBungeCATCaterpillar
  15. Issued Dec 23, 2025

    Increasing Medical Marijuana and Cannabidiol Research

    This executive order directs the Attorney General to expedite rescheduling marijuana from Schedule I to Schedule III of

    EO 143706/10LicensingProcurementPharmaAgIndustrialUS
    MMM3MAAPLAppleADMArcher Daniels MidlandBGBungeCATCaterpillarCTVACortevaLLYEli LillyFCXFreeport-McMoRan
  16. Issued Oct 7, 2025

    Unlocking Cures for Pediatric Cancer With Artificial Intelligence

    This executive order directs the Make America Healthy Again (MAHA) Commission and health agencies to leverage artificial

    EO 143556/10Subsidy / incentiveProcurementTechPharmaIndustrialUS
    MMM3MGOOGLAlphabetAAPLAppleCATCaterpillarLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywell
Policy market alerts · Executive Orders